
Sign up to save your podcasts
Or
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill’s conclusions.
5
1717 ratings
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill’s conclusions.
129 Listeners
313 Listeners
488 Listeners
113 Listeners
264 Listeners
3,317 Listeners
1,071 Listeners
113 Listeners
115 Listeners
169 Listeners
60 Listeners
6 Listeners
170 Listeners
11 Listeners
5 Listeners